Both in Pharmaceuticals
Aardvark Therapeutics vs NextCure
Over the past year AARD returned −86.9% and NXTC returned −47.3%; their daily moves had a correlation of 0.05.
AARD −86.9% NXTC −47.3%Growth of $1, one year, split-adjusted
| Metric | AARD | NXTC |
|---|---|---|
| Price | $1.36 | $6.31 |
| Market cap | $29.8M | $28.9M |
| Today | −5.56% | −3.29% |
| 1 month | −74.2% | +27.2% |
| 6 months | −75.1% | −32.6% |
| Year to date | −89.6% | −55.5% |
| 1 year | −88.1% | −47.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $73.9M | $20.1M |
| Dividend yield | — | — |
| Volatility (60d) | 240.8% | 113.8% |
| Short % of float | 4.6% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).